News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BeiGene Co.,Ltd Signs China CMO Deal With Boehringer Ingelheim Corporation


9/4/2014 2:41:40 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

September 3, 2014 -- BeiGene, a Beijing innovative drug development company, signed a contract manufacturing agreement with Boehringer Ingelheim that calls for BI to produce BeiGene's drugs at its Shanghai biopharma facility. BI's $82 million plant, located in the Zhangjiang Hi-Tech Park, is currently under construction and should be complete next year. Last week, in a separate announcement, BeiGene said its third molecule had started a clinical trial, underscoring its need for a CMO partner.

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES